期刊档案 · 医学-寄生虫学
Acta Tropica
ISSN 0001-706X · eISSN 1873-6254 · Elsevier · NETHERLANDS · Monthly · 创刊 1944
Acta Tropica 中科院 医学 3区（2025 年升级版），影响因子 2.54，混合开放获取，APC 约 3,160 美元，近 24 个月 122 篇文章投稿到接收中位 89 天，录用比例容易（社区反馈），2025 年发文 418 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Acta Tropica 由 Elsevier 出版，属中科院医学大类（2025 升级版3区）。按 OpenAlex 近年发文统计，该刊主要发表 Parasites and Host Interactions、Mosquito-borne diseases and control、Research on Leishmaniasis Studies 等主题的论文，这 3 个主题约占 29.1%，主导子领域为 Parasitology、Public Health, Environmental and Occupational Health。（根据 OpenAlex 主题统计与中科院分区数据生成）
Acta Tropica is an international journal on infectious diseases that covers public health sciences, medical and veterinary entomology, and biomedical research with particular emphasis on topics relevant to human and animal health.Its scope includes the biology of pathogens and vectors, host-parasite relationships, mechanisms of pathogenicity, clinical disease and chemotherapy. We welcome contributions in basic or applied research in disciplines such as epidemiology, disease ecology, diagnostics, interventions and control, drug and insecticide resistance, mathematical modelling, public health and social sciences, climate change, parasite and vector taxonomy, biology, ecology and behaviour, host and parasite genomics, biochemistry, immunology, and vaccine testing.Contributions may be in the form of original research papers, review articles, short communications, opinion articles, or letters to the Editors.Only manuscripts of high scientific significance and innovation will be considered for publication. Criteria for rejection without review:Out of scopeManuscripts of minimal international relevance, including regional reports and studies of local interestCase reportsParasite and vector control strategies at very early inconclusive laboratory stages of development. For vector control studies, field validation is requiredField studies not replicated at least over two yearsStudies dealing with natural products (e.g., plant extracts) not characterized from a chemical point of view.Ethical issues, including plagiarism, submission of the manuscript to multiple journals, and lack of ethical approval where needed.Important Guidelines for AcceptanceEditors and the Editorial Board of Acta Tropica provide the following guidelines to help authors prepare manuscripts of high quality that can be considered for publication. Maximize your chances of acceptance by making sure your manuscript:Matches the scientific scope of the journalFollows the instructions specified in Acta Tropica guide for authorsPresents results that significantly advance science including innovative new approachesMeets quality standards of presentation and literature citationDemonstrates potential health or biomedical impact.The above points are critical for the publication of original papers. Be aware Editors carefully evaluate initial manuscript submissions and only those meeting the above criteria will be forwarded to review. If reviewed favourably and the authors seriously address all concerns, then chances of acceptance are increased. Review and Opinion articles may be invited by the Editors in Chief or submitted by authors responding to a recognized need. Reviews are expected to carefully synthesize and discuss the literature and make recommendations to advance respective scientific fields. Reviews and Opinions submitted by authors without research experience on the topic covered by the manuscript will not be considered. Systematic reviews adhering to PRISMA guidelines and meta-analyses are welcome. For any inquiry about Reviews and Opinions please contact our Special Content Editor, Prof. John Beier.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：医学-寄生虫学
主编 Nicola Decaro出版商官网
编委会国家分布：中国大陆 8 位（约 12%）；主要国家 意大利 14、美国 10、中国 8、巴西 6、德国 4（共 66 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Parasites and Host InteractionsImmunology and Microbiology10%
- Mosquito-borne diseases and controlMedicine9.8%
- Research on Leishmaniasis StudiesMedicine9.4%
- Trypanosoma species research and implicationsMedicine9.2%
- Malaria Research and ControlMedicine8%
- Parasite Biology and Host InteractionsEnvironmental Science6.3%
- Viral Infections and VectorsMedicine4.8%
- Vector-borne infectious diseasesImmunology and Microbiology3.9%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 热带医学TROPICAL MEDICINE | 2 区 |
| 小类 | 寄生虫学PARASITOLOGY | 3 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 寄生虫学PARASITOLOGY | 3 区 |
| 小类 | 热带医学TROPICAL MEDICINE | 2 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 热带医学TROPICAL MEDICINE | 2 区 |
| 小类 | 寄生虫学PARASITOLOGY | 3 区 |
Top 期刊：否综述期刊：否
数据库收录
SCIEScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 2.54LetPub ·
- 影响因子（出版商公布）
- 2.6出版商官网 ·
- CiteScore 2026-06
- 4.7LetPub ·
- CiteScore（出版商公布）
- 4.7出版商官网 ·
- SJR 2026-06
- 0.68LetPub ·
- SNIP 2026-06
- 0.98LetPub ·
- h-index
- 89LetPub ·
- h-index
- 155OpenAlex ·
- i10-index
- 5,081OpenAlex ·
- 两年平均被引
- 2.57OpenAlex ·
- 自引率
- 7.7%LetPub ·
- Gold OA 文章占比
- 19.22%LetPub ·
发文规模
- 年文章数
- 400LetPub ·
逐年发文量 OpenAlex 统计 · 累计 8,393 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 375 | 120 | 117 |
| 2025 | 418 | 106 | 805 |
| 2024 | 402 | 134 | 2,145 |
| 2023 | 272 | 80 | 2,462 |
| 2022 | 396 | 118 | 4,573 |
| 2021 | 398 | 111 | 5,869 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 PubMed 登记的稿件日期 · 至
89 天投稿到接收中位数 · P25–P75 63 天 – 114 天
- 接收到上线
- 中位数 1 天（122 篇）
- 投稿到上线
- 中位数 92 天
- 样本
- 122 篇有投稿与接收日期的文章（窗口内共 947 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 一般,3-8周来源Elsevier官网：平均11.1周LetPub ·
- 平均录用比例（社区反馈）
- 容易LetPub ·
- 投稿到首次决定
- 4 天出版商官网 ·
- 外审后首次决定
- 30 天出版商官网 ·
- 投稿到接收
- 69 天出版商官网 ·
- 接收到发表
- 2 天出版商官网 ·
- 评审方式
- 单盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
混合开放获取LetPub
订阅期刊，作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 3,160 / EUR 2,960 / GBP 2,530 / JPY 391,930 | — | — | |
| 出版商官网 | USD 3,350 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
征稿中的专刊5 个，按截稿日期
- Integrated Mosquito Management (IMM) in the United States: From Concept to Field Implementation截稿
- Resilient Futures in Tropical Veterinary Medicine: Leveraging Research, Artificial Intelligence and Crisis Response to Combat Emerging Diseases and Safeguard Food Security截稿
- New Challenges and Role of Innovative Technology on Dengue Prevention and Control: the 2025 APEC Conference on Dengue Prevention and Control in the Post-COVID-19 Era截稿
- The social ecology of tropical zoonotic and vector-borne diseases截稿
- Advances in MALDI-TOF mass spectrometry for the identification of blood-feeding arthropods: reference databases and applications in human and animal health截稿
投稿准备要点1 项，摘自作者指南
- 摘要
- ≤ 250 词
接收的文章类型14 种，含篇幅限制
- full paperOriginal research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words …未说明篇幅
- letters to the editorit to both the journal and its readers. Letters to the Editor are limited to 2,000 words per article (all text excluding tables and figure legends).正文 ≤ 2,000 词
- meta-analysisOriginal research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words …未说明篇幅
- opinionyears to achieve public health impact. Opinion articles are limited to 6,000 words per article (all text excluding tables and figure legends).正文 ≤ 6,000 词
- opinion articlesOpinion articles should include scientifically backed points of view regarding currently relevant, controversial or future-oriented topics pertinent to the scop…未说明篇幅
- original articleOriginal research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words …正文 ≤ 7,000 词
- original research articleOriginal research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words …未说明篇幅
- original research articlesOriginal research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words …未说明篇幅
- protocolOriginal research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words …未说明篇幅
- reviewOriginal research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words …未说明篇幅
- review articleOriginal research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words …正文 ≤ 15,000 词
- short communicationOriginal research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words …正文 ≤ 3,000 词
- short communicationsShort Communications should consist of original results or new methods within the scope of the journal. Short Communications need not be formally structured as …未说明篇幅
- systematic reviewOriginal research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words …未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、许可与版权、开放获取、同行评审、预印本
- AI 使用 Declaration of generative AI use
作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
原文 ↗出版商官网 ·- 作者资格 Group authorship
集体署名指将文章归属于一个明确且命名的作者群体，须在投稿时于标题页声明。 模型中文摘要
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
原文 ↗出版商官网 ·- 利益冲突 Declaration of competing interests
所有作者必须披露任何可能不当影响或偏颇其工作的财务和个人关系。 模型中文摘要
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
原文 ↗出版商官网 ·- 许可与版权 License options
作者将获得开放获取用户许可选项，建议在选择许可前审查这些选项及资助机构的许可要求。 模型中文摘要
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
原文 ↗出版商官网 ·- 开放获取 Open access
本刊提供开放获取选项，作者可参阅开放获取信息页面了解详情。 模型中文摘要
We refer you to our open access information page to learn about open access options for this journal.
原文 ↗出版商官网 ·- 同行评审 Peer review
本刊采用单盲同行评审，投稿将首先由编辑评估，随后通常送至少两名审稿人进行独立专家评估。 模型中文摘要
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
原文 ↗出版商官网 ·- 预印本 Preprints
作者可按照爱思唯尔文章共享政策分享预印本，分享预印本不计作先前发表。 模型中文摘要
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Elsevier
- 出版国家或地区
- NETHERLANDS
- 出版语言
- English
- 出版周期
- Monthly
- 创刊年份
- 1944
- ISSN
- 0001-706X
- 电子版 ISSN
- 1873-6254
- 官方链接
- 期刊主页 ↗LetPub
- 投稿系统 ↗出版商官网
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Acta Tropica 的常见问题
Acta Tropica 是中科院几区期刊？
2025 年升级版分区表中，Acta Tropica 为医学 3区，小类 热带医学 / 寄生虫学 2 区。2026 年新锐版分区表中为医学 3区。不同版本与大小类分区不能混用。
Acta Tropica 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 2.54，CiteScore 为 4.7，h-index 为 155。
Acta Tropica 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）122 篇已发表文章登记的日期，投稿到接收的中位数为 89 天（四分位 63–114 天）；投稿社区反馈的平均审稿速度为3–8 周，平均录用比例反馈为“容易”。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Acta Tropica 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 66 位编委中，中国大陆 8 位（约 12%）；人数最多的国家是 意大利（14 位）、美国（10 位）、中国（8 位）。统计按编委会页面列出的机构国家计，仅供参考。
Acta Tropica 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Acta Tropica 被 SCIE、Scopus 收录。
Acta Tropica 是开放获取期刊吗？版面费多少？
Acta Tropica 为混合开放获取。选择开放获取发表时APC 约 3,160 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-25 归档）。最近更新：。